Beranda › Kanker (semua jenis) › Texas › San Antonio
Uji klinis Kanker (semua jenis) di San Antonio, TX
41 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar San Antonio (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of ASP3082 in Adults With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology, San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- PHN-012-001 Site, San Antonio
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Menerima pesertaFase 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
Menerima pesertaFase 1
- NEXT Oncology ( Site 0151), San Antonio
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Menerima pesertaFase 2
- Mays Cancer Center ( Site 0039), San Antonio
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- GSK Investigational Site, San Antonio
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology, San Antonio
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Menerima pesertaFase 3
- START San Antonio ( Site 0104), San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Menerima pesertaFase 2/3
- Sam Clinical Research Center, San Antonio
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Menerima pesertaFase 1/2
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology, San Antonio
Prostate Active Surveillance Study
Menerima pesertaStudi observasional
- University of Texas Health Science Center, San Antonio, San Antonio
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Menerima pesertaFase 3
- Texas Oncology-San Antonio Cancer Care, San Antonio
- Texas Oncology - San Antonio Northeast, San Antonio
- Texas Oncology - San Antonio Stone Oak, San Antonio
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Menerima pesertaFase 1
- NEXT Oncology, San Antonio
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Menerima pesertaFase 1/2
- Site 01, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Menerima pesertaFase 1
- NEXT Oncology San Antonio, San Antonio
- START- San Antonio, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- UT Health Mays Cancer Center, San Antonio
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Menerima pesertaFase 1
- NEXT Oncology, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Menerima pesertaFase 1
- START San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
Menerima pesertaFase 1
- South Texas Accelerated Research Therapeutics, San Antonio
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Menerima pesertaFase 3
- Texas Oncology San Antonio Medical Center, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- START San Antonio, LLC., San Antonio
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology, San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Menerima pesertaFase 1
- USA Clinical Trials, San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- START San Antonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
- START, San Antonio
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Menerima pesertaFase 1
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Menerima pesertaFase 1
- Research Site #2, San Antonio
- Research Site, San Antonio
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Menerima pesertaFase 1
- GSK Investigational Site, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Menerima pesertaFase 1/2
- NEXT Oncology, San Antonio
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT San Antonio, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology San Antonio, San Antonio
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- UT Health, San Antonio
A Study of YL242 in Subjects With Advanced Solid Tumors
Menerima pesertaFase 1/2
- US-207, San Antonio
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
Menerima pesertaFase 1
- NEXT Oncology, San Antonio
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
Menerima pesertaFase 1
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Menerima pesertaFase 1/2
- NEXT Oncology, San Antonio
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- University of Texas Health Science Center at San Antonio, San Antonio
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Studi lain di San Antonio
- Kanker Paru Non-Sel Kecil59 studi
- Kanker Kolorektal46 studi
- Kanker Payudara46 studi
- Kanker Metastatik44 studi
- Obesitas40 studi
- Diabetes Tipe 237 studi
- Kelebihan Berat Badan34 studi
- Kanker Ovarium31 studi
- Kanker Pankreas31 studi
- Kanker Prostat28 studi
- Kanker Endometrium27 studi
- Kanker Paru26 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.